MNKD:NASDAQ
MannKind Corp
$4.13
arrow_downward
-0.72%(-0.030) 1D
$4.13
0.00% (0.00)
bedtimeAfter hours
Closed: Nov 13, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MNKD...
Open
$4.15
High
$4.18
Low
$4.08
Mkt. cap
1.33B
Avg. vol.
3.74M
Volume
1.69M
52-wk high
$6.51
52-wk low
$2.23
EPS
-$0.24
Beta
1.10
Shares outstanding
321.64M
No. of employees
592
Open
$4.15
High
$4.18
Low
$4.08
Mkt. cap
1.33B
Avg. vol.
3.74M
Volume
1.69M
52-wk high
$6.51
52-wk low
$2.23
EPS
-$0.24
Beta
1.10
Shares outstanding
321.64M
No. of employees
592
News stories
From web sources and news partners
Seeking Alpha
·
18 hours ago
MannKind: The ReadyFlow Launch Must Fund The Company Built Around It (NASDAQ:MNKD)
Profile
MannKind Corporation is a biopharmaceutical company focusing on the discovery, development, and commercialization of therapeutic products for diseases such as diabetes and pulmonary arterial hypertension. Based in Danbury, Connecticut, the company was founded in February 1991.
MannKind Corporation was named after its founder, Alfred E. Mann. Wikipedia
About MannKind Corp
CEOMichael Castagna
Employees592
FoundedFeb 1991
HeadquartersDanbury, Connecticut, United States
SectorHealth Care
IndustryBiotechnology
Websitemannkindcorp.com